The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality

1. Abu-Soud H.M., S.L. Hazen (2000) Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem., 275: 37524-37532.Search in Google Scholar

2. Ahmed H.M., M.J. Blaha, K. Nasir, J.J. Rivera, R.S. Blumenthal (2012) Effects of physical activity on cardiovascular disease. Am. J. Cardiol.,109: 288-295.10.1016/j.amjcard.2011.08.042Search in Google Scholar

3. Aldridge W.N. (1953) Serum esterases. I. Two types of esterase (A and B) hydrolyzing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. Biochem. J., 53: 110-117.Search in Google Scholar

4. Andersen C.J., M.L. Fernandez (2013) Dietary approaches to improving atheroprotective HDL functions. Food Func., 4: 1304-1313. DOI: 10.1039/c3fo60207a.10.1039/c3fo60207aSearch in Google Scholar

5. Andrews P.C., N.I. Krinsky (1981) The reductive cleavage of myeloperoxidase in half, producing enzymatically active hemi-myeloperoxidase. J. Biol. Chem., 256: 4211-4218.Search in Google Scholar

6. Arunima S., T. Rajamohan (2013) Effect of virgin coconat oil enriched diet on the antioxidant status and paraoxonase 1 activity in ameliorating the oxidative stress in rats – a comparative study. Food Func., 4: 1402-1409.Search in Google Scholar

7. Atli M. (2013) Serum paraoxonase activity and lipid hydroperoxide levels in adult football players after three days football tournament. Afr. Health. Sci., 13: 565-570.Search in Google Scholar

8. Aviram M., M. Rosenblat, S. Billecke, J. Erogul, R. Sorenson, C.L. Bisgaier (1999) Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med., 26: 892-904.Search in Google Scholar

9. Aviram M., M. Rosenblat, C.L. Bisgaier, R.S. Newton, S.L. Primo-Parmo, B.N. La Du (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest., 101: 1581-1590.Search in Google Scholar

10. Barter P. (2011) HDL-C: role as a risk modifier. Atherosclerosis (Suppl). 12: 267-270.10.1016/S1567-5688(11)70885-6Search in Google Scholar

11. Belcastro A.N., G.D. Arthur, T.A. Albisser, D.A. Raj (1996) Heart, liver, and skeletal muscle myeloperoxidase activity during exercise. J. Appl. Physiol., 80: 1331-1335.Search in Google Scholar

12. Blazek A., J. Rutsky, K. Osei, A. Maiseyeu, S. Rajagopalan (2013) Exercise-mediated changes in high-density lipoprotein: impact on form and function. Am. Heart J., 166: 392-400.10.1016/j.ahj.2013.05.02124016485Search in Google Scholar

13. Brennan M.L., M.M. Anderson, D.M. Shih, X.D. Qu, X. Wang, A.C. Metha (2001) Increased atherosclerosis in myeloperoxidase deficient mice. Clin. Invest., 107: 419-430.Search in Google Scholar

14. Brewis I.A., P. Brennan (2010) Proteomics technologies for the global identification and quantification of proteins. Adv. Protein. Chem. Struct. Biol., 80: 1-44.Search in Google Scholar

15. Cakmak A., D. Zeyrek, A. Atas, O. Erel (2010) Paraoxonase activity in athletic adolescents. Pediatr. Exerc. Sci., 22: 93-104.Search in Google Scholar

16. Chapman M.J., H.N. Ginsberg, P. Amarenco, F. Andreotti, J. Borén, A.L. Catapano (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart J., 32: 1345-1361. DOI: org/10.1093/eurheartj/ehr112.Search in Google Scholar

17. Chen L.Q., A. Rohatgi, C.R. Ayers, S.R. Das, A. Khera, J.D. Berry (2011) Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study. Atherosclerosis, 219: 833-838.10.1016/j.atherosclerosis.2011.08.029322688321917261Search in Google Scholar

18. Costa L.G., G. Giordano, C.E. Furlong (2011) Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem. Pharmacol., 81: 337-344. DOI: 10.1016/jbcp2010.11.008.Search in Google Scholar

19. Danesh J. (2012) Lipid-related markers and cardiovascular disease prediction. JAMA, 307: 2499-2506.Search in Google Scholar

20. de Ross N.M., E.G. Schouten, L.M. Schek, A. van Toi, M.B. Katan (2002) Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metabolism, 51: 1534-1537.10.1053/meta.2002.3630512489064Search in Google Scholar

21. Delporte C., K.Z. Boudjeltia, C. Noyon, P.G. Furtmüller, V. Nuyens, M.C. Slomianny (2014) Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100. J. Lipid. Res., 55: 747-757.Search in Google Scholar

22. Farid A.S., Y. Horii (2012) Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis. Lipids Health Dis., 11: 92.Search in Google Scholar

23. Flock M.R., P.M. Kris-Etherton (2010) Dietary guidelines for Americans implications for cardiovascular disease. Curr. Atheroscler. Rep., 13: 499-507. DOI: 10.1007/s11883-011-0205-0.10.1007/s11883-011-0205-021874316Search in Google Scholar

24. Gharakhanlou R., M.E. Afzalpour, A.A. Gaeini, N. Rahnamam (2007) Effects of aerobic exercises on the serum paraoxonase 1/arylesterase activity and lipid profile in non-active healthy men. Int. J Sports Sci. Eng., 1: 105-112.Search in Google Scholar

25. Gordon S.M., J. Deng, L.J. Lu, W.S. Davidson (2010) Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J. Proteome Re., 9: 5239-5249.Search in Google Scholar

26. Hafiane A., J. Genest (2015) High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. BBA Clinical., 3: 175-188.Search in Google Scholar

27. Haraguchi Y., R. Toh, M. Hasokawa, H. Nakajima, T. Honjo, K. Otsui (2014) Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease. Atherosclerosis, 234: 288-294.10.1016/j.atherosclerosis.2014.03.00924704632Search in Google Scholar

28. Hazen S.L., J.W. Heinecke (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest., 99: 2075-2081.Search in Google Scholar

29. Hedric C.C., K. Hassan, G.P. Hough, J.H. Yoo, S. Simzar, C.R. Quinto (2000) Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Arterioscler. Thromb. Vasc. Biol., 20: 1946-1952.Search in Google Scholar

30. Hewing B., K.J. Moore, E.A. Fisher (2012) HDL and cardiovascular risk: time to call the plumber? Circ. Res., 111: 1117-1120.Search in Google Scholar

31. Huang J., H. Lee, A.M. Zivkovic, J.T. Smilowitz, N. Rivera, J. German (2014) Glycomic analysis of high density lipoprotein shows a highly sialylated particle. Proteome. Res., 13: 681-691.Search in Google Scholar

32. Huang Y., Z. Wu, M. Riwanto, S. Gao, B.S. Levison, X. Gu (2013) Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J. Clin. Invest., 123: 3815-3828.Search in Google Scholar

33. Ibero-Baraibar I., I. Abete, S. Navas-Carretero, A. Massis-Zaid, J.A. Martinez (2014) Oxidize LDL levels decreases after the consumption of ready-to-eat meals supplemented with coca extract with hypochloric diet. Nutr. Meta. Cardiovasc. Dis., 24: 416-422.Search in Google Scholar

34. Kameda T., R. Ohkawa, K. Yano, Y. Usami, A. Miyazaki, K. Matsuda (2015) Effects of myeloperoxidase-induced oxidation on antiatherogenic functions of high-density lipoprotein. J. Lipids. DOI: 10.1155/2015/592594.10.1155/2015/592594451684726257958Search in Google Scholar

35. Kaur N., A. Pandey, H. Negi, N. Shafiq, S. Reddy, H. Kaur (2014) Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression. PLoS One. DOI: 10.1371/journal.pone.0094585.10.1371/journal.pone.0094585398417124728455Search in Google Scholar

36. Khersonsky O., D.S. Tawfik (2005) Structure-reactivity of serum paraoxonase PON1 suggests that its native activity is lactonase. Biochemistry, 44: 6371-6382.10.1021/bi047440d15835926Search in Google Scholar

37. Kim D.S., A.A. Burt, J.E. Ranchalis, R.J. Richter, J.K. Marshall, K.S. Nakayama (2012) Dietary cholesterol increases paraoxonase 1 activity. J. Lipid. Res., 53: 2450-58. doi: 10.1194/jlr.PO30601.Search in Google Scholar

38. Kim D.S., S.K. Maden, A.A. Burt, J.E. Ranchalis, C.E. Furlong, G.P. Jarvik (2013) Dietary fatty acid intake is associated with paraoxonase 1 activity in cohort-based analysis of 1,548 subjects. Lipids Health Dis., 12: 183. DOI: 10.1186/1476-511X-12-183.10.1186/1476-511X-12-183387882524330840Search in Google Scholar

39. Kitchen B.J., C.J. Masters, D.J. Winzor (1973) Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase. Biochem., 135: 93-99. 40. Kontush A., M. Lhomme, M.J. Chapman (2013) Unraveling the complexities of the HDL lipidome. J. Lipid. Res., 54: 2950-2963.Search in Google Scholar

41. Kristensen L.P., M.R. Larsen, H. Mickley, L. Saaby, A.C. Diederichsen, J. Lambrechtsen (2014) Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. J. Proteomics., 101: 141-153.Search in Google Scholar

42. Lau D., S. Baldus (2006) Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol. Ther., 111: 16-26.Search in Google Scholar

43. Libby P. (2015) ALX-chemy: adding spice to the inflammatory soup of atherosclerosis. Cardiovasc. Res., 105: 3-5.Search in Google Scholar

44. Loued S., H. Berrougui, P. Componova, S. Ikhlef, O. Helel, A. Khalil (2013) Extra-virgin olive oil consumption reduces atherosclerosis and age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities. Br. J. Nutr., 110: 1272-1284.Search in Google Scholar

45. Maceyka M., K.B. Harikumar, S. Milstien, S. Spiegel (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends. Cell. Biol., 22: 50-60.Search in Google Scholar

46. Mackness M., A. Boullier, N. Hennuyer, B. Mackness, M. Hall, A. Tailleux (2000) Paraoxonase activity is reduced by a pro-athrosclerotic diet in rabbits. Biochem. Biophys. Acta., 269: 232-236.Search in Google Scholar

47. Mackness M.I., S.D. Hallam, T. Peard, S. Warner, C.H. Walker (1985) The separation of sheep and human serum “A”-esterase activity into the lipoprotein fraction by ultracentrifugation. Comp. Biochem. Physiol. B., 82: 675-677.Search in Google Scholar

48. Mackness M.I., B. Mackness, P.N. Durrington, P.W. Connelly, R.A. Hegele (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr. Opin. Lipidol., 7: 69-76.Search in Google Scholar

49. Mahdy Ali K., A. Wonnerth, K. Huber, J. Wojta (2012) Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities. Br. J. Pharmacol., 167: 1177-1194.Search in Google Scholar

50. Mangge H., K. Becker, D. Fuchs, J.M. Gostner (2014) Antioxidants, inflammation and cardiovascular disease. World. J. Cardiol., 6: 462-477.Search in Google Scholar

51. Mann S., C. Beedie, A. Jimenez (2014) Differential effects of aerobic exercise, resistance exercise training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med., 2: 211-21. DOI: 10.1007/s40279-013-0110-5.10.1007/s40279-013-0110-5390654724174305Search in Google Scholar

52. Melanson S.E., S.M. Green, M.J. Wood, T.G. Neilan, E.L. Lewandowski (2006) Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running. Am. J. Clin. Pathol., 126: 888-893.Search in Google Scholar

53. Morozov V.I., S.A. Pryatkin, M.I. Kalinski, V.A. Rogozkin (2003) Effect of exercise to exhaustion on myeloperoxidase and lysozyme release from blood neutrophils. Eur. J. Appl. Physiol., 89: 257-262Search in Google Scholar

54. Morozov V.I., P.V. Tsyplenkov, N.D. Golberg, M.I. Kalinski (2006) The effects of high-intensity exercise on skeletal muscle neutrophil myeloperoxidase in untrained and trained rats. Eur. J. Appl. Physiol., 97: 716-722.Search in Google Scholar

55. Mozaffarian D. (2016) Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: A Comprehensive Review. Circulation, 13: 187-225.10.1161/CIRCULATIONAHA.115.018585481434826746178Search in Google Scholar

56. Nakajima T., M. Kurano, H. Takano, H. Iida, T. Fukuda, K. Meguro (2010) Acute high-intensity exercise releases myeloperoxidase and pentraxin 3 from peripheral neutrophils in healthy subjects. Circulation, 122: Abstract 13270.Search in Google Scholar

57. Nalcakan G.R., S.R. Varol, F. Turgay, M. Nalcakan, M.Z. Ozkol, S.O. Karamizrak (2015) Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women. J. Sport. Health Sci., 4: 1-7.Search in Google Scholar

58. Natarajan P., K.K. Ray, C.P. Cannon (2010) High-density lipoprotein and coronary heart disease: current and future therapies. J. Am. Coll. Cardiol., 55: 1283-1299.Search in Google Scholar

59. Nauseef W.M., I. Olsson, K. Arnijots (1988) Biosynthesis and processing of myeloperoxidase – a marker for myeloid differentiation. Eur. J. Hematol., 40: 97-110.Search in Google Scholar

60. Navab M., S.T. Reddy, B.J. Van Lenten, G.M. Anantharamaiah, A.M. Fogelman (2009) The role of dysfunctional HDL in atherosclerosis. J. Lipid. Res., 50: S145-S149.10.1194/jlr.R800036-JLR200267472018955731Search in Google Scholar

61. Nichols M., N. Townsend, P. Scarborough, M. Rayner (2014) Cardiovascular disease in Europe 2014: epidemiological update. Eur. Heart J., 35: 2929.Search in Google Scholar

62. Nussbaum C., A. Klinke, M. Adam, S. Baldus, M. Sperandio (2013) Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxid. Redox Signal., 18: 692-713.Search in Google Scholar

63. Otocka-Kmiecik A., M. Lewandowski, R. Stolarek, U. Szkudlarek, D. Nowak, M. Orłowska-Majdak (2010) Effect of single bout of maximal exercise on plasma antioxidant status and paraoxonase activity in young sportsmen. Redox Rep., 15: 275-281.Search in Google Scholar

64. Otocka-Kmiecik A., M. Lewandowski, U. Szkudlarek, D. Nowak, M. Majdak-Orłowska (2014) Aerobic training modulates the effects of exercise-induced oxidative stress on PON1 activity: a preliminary study. Sci. World J. DOI: 10.1155/2014/230271.10.1155/2014/230271421403825379522Search in Google Scholar

65. Pareja-Galeano H., N. Garatachea, A. Lucia (2015) Exercis as a polypill for chronic disese. Prog. Mol. Biol. Transl. Sci., 135: 497-526.Search in Google Scholar

66. Podrez E.A., D. Schmitt, H.F. Hoff, S.L. Hazen (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest., 103: 1547-1560.Search in Google Scholar

67. Précourt L.P., D. Amre, M.C. Denis, J.C. Lavoie, E. Delvin, E. Seidman (2011) The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis, 214: 20-36.10.1016/j.atherosclerosis.2010.08.07620934178Search in Google Scholar

68. Primo-Parmo S.L., Sorenson R.C., Teiber J., B.N. La Du (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics, 33: 498-507.10.1006/geno.1996.02258661009Search in Google Scholar

69. Razavi A.E., G. Basati, J. Varshosaz, S. Abdi (2013) Association between HDL particles size and myeloperoxidase/paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome. Acta Medica Iranica, 51: 365-371.Search in Google Scholar

70. Reihmane D., A. Jurka, P. Tretjakovs (2012) The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations. Scand. J. Immunol., 76: 188-192.Search in Google Scholar

71. Rezaee F., B. Casetta, J.H. Levels, D. Speijer, J.C. Meijers (2006) Proteomic analysis of high-density lipoprotein. Proteomics, 6: 721-730.10.1002/pmic.20050019116419016Search in Google Scholar

72. Richter B., A. Niessner, M. Penka, M. Grdić, S. Steiner, B. Strasser (2005) Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Throm. Haemost., 94: 1306-1311.Search in Google Scholar

73. Roberts C.K., A.K. Chen, R.J. Barnard (2007) Effect of a short-term diet and exercise intervention in youth on atherosclerotic factors. Atherosclerosis, 191: 98-106.10.1016/j.atherosclerosis.2006.09.01117054960Search in Google Scholar

74. Rosenson R.S., H.B. Brewer, B. Ansell, P. Barter, M.J. Chapman, J.W. Heinecke, A. Kontush, A.R. Tall, N.R. Webb (2013) Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges. Circulation, 128: 1256-1267.10.1161/CIRCULATIONAHA.113.000962Search in Google Scholar

75. Shao B., C. Tang, A. Sinha, P.S. Mayer, G.D. Davenport, N. Brot (2014) Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase. Circ. Res., 114: 1733-1742.Search in Google Scholar

76. Shekhanawar M., S.M. Shekhanawar, D. Krisnaswamy, V. Indumati, D. Satishkumar, V. Vijay (2013) The role of ‘paraoxonase-1 activity’ as an antioxidant in coronary artery diseases. J. Clin. Diagn. Res., 7: 1284-1287.Search in Google Scholar

77. Sini S., N. Jayakumari (2013) Functionally defective high density lipoprotein is pro-oxidant: a deviation from normal atheroprotective character. Inter. J. Nutr. Food Sc., 2: 92-101.Search in Google Scholar

78. Sorenson R.C., S.L. Primo-Parmo, C.L. Kuo, S. Adkins, O. Lockridge, B.N. La Du (1995) Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. USA., 92: 7187-7191.Search in Google Scholar

79. Stancu C.S., L. Toma, A.V. Sima (2012) Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell Tissue Res., 349: 433-446.Search in Google Scholar

80. Tang W.H., J. Hartiala, Y. Fan, Y. Wu, A.F. Stewart, J. Erdmann (2012) Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler. Thromb. Vasc. Biol., 32: 2803-2812.Search in Google Scholar

81. Taylor J.K., E.P. Plaisance, A.J. Mahurin, M.L. Mestek, J. Moncada-Jimenez, P.W. Grandjean (2015) Paraoxonas response to exercise and niacin therapy in men with metabolic syndrome. Redox Rep., 20: 42-48. DOI: 10.1179/1351000214Y.0000000103.10.1179/1351000214Y.0000000103Search in Google Scholar

82. Tomás M., M. Sentí, F. García-Faria, J. Vila, A. Torrents, M. Covas (2000) Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol., 20: 2113-2119.Search in Google Scholar

83. Turgay F., A.R. Şişman, A.C. Aksu (2015) Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1-Q192R phenotype. J. Atheroscler. Thromb., 22: 313-326.Search in Google Scholar

84. Vakili L., K.D. Navab, M. Shabihkhani, N. Pourtabatabaei, S. Vazirian, Z. Barseghian (2014) Systemic inflammation, intestine, and paraoxonase-1. Adv. Exp. Med. Biol., 824: 83-88.Search in Google Scholar

85. Van der Veen B.S., M.P. de Winther, P. Heeringa (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signal., 11: 2899-937.Search in Google Scholar

86. Verdier C., L.O. Martinez, J. Ferriéres, M. Elbaz, A. Gennoux, B. Perret (2013) Targeting high-density lipoproteins: update on a promising therapy. Arch. Cardiovasc. Dis., 106: 601-611.Search in Google Scholar

87. Vickers K.C., A.T. Remaley (2014) HDL and cholesterol: life after the divorce? J. Lipid. Res., 55: 4-12.Search in Google Scholar

88. Villella M., A. Villela (2014) Exercise and cardiovascular disea se. Kidney Blood Press. Res., 39: 147-153. DOI: 10.1159/000355790.10.1159/000355790Search in Google Scholar

89. Voight B.F., G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M.K. Jensen (2012) Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomization study. Lancet, 380: 572-580.10.1016/S0140-6736(12)60312-2Search in Google Scholar

90. Wang F., Y. Liu, Y. Cong, P. Li, Y. Li, Z. Yan (2015) Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: a marker of atherosclerosis in patients with normal cholesterol levels. Clin. Chim. Acta, 438: 370-375.10.1016/j.cca.2014.09.02025269090Search in Google Scholar

91. Wieslander G., N. Fabjan, M. Vogrinčič, I. Kreft, C. Janson, U. Spetz-Nyström (2011) Eating buckwheat cookies is associated with the reduction in serum levels of myeloperoxidase and cholesterol: a double blind crossover study in day-care centre staffs. Tohoku. J. Exp. Med., 225: 123-130.10.1620/tjem.225.12321931228Search in Google Scholar

92. Witte I., U. Foerstermann, A. Devarajan, S.T. Reddy, S. Horke (2012) Protectors or traitors: the roles of PON2 and PON3 in atherosclerosis and cancer. J. Lipids. DOI: 10.1155/2012/342806.10.1155/2012/342806336122822666600Search in Google Scholar

93. Wong N.D., H. Gransar, J. Narula, L. Shaw, J.H. Moon, R. Miranda-Peats (2009) Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. JACC Cardiovasc. Imaging, 2: 1093-1099.Search in Google Scholar

94. Wysocka A., M. Cybulski, H. Berbeć, A. Wysokiński, J. Stążka, T. Zapolski (2014) Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery. Med. Sci. Monit., 20: 594-600.Search in Google Scholar

95. Yin X., S. Subramanian, S.J. Hwang, C.J. O’Donnell, C.S. Fox, P. Courchesne (2014) Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative. Arterioscler. Thromb. Vasc. Biol., 34: 939-945.Search in Google Scholar

96. Youseff H., C. Groussard, S. Lemoine-Morel, J. Pincemail, C. Jacob, E. Moussa (2015) Aerobic training suppresses exercise-induced lipid peroxidation and inflammation in overweight/obese adolescent girls. Pediatr. Exerc. Sci., 27: 67-76. DOI: 10.1123/pes.2014-0008.10.1123/pes.2014-000825387489Search in Google Scholar

97. Zhu Y., X. Huang, Y. Zhang, Y. Wang, Y. Liu, R. Sun (2014) Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. J. Clin. Endocrinol. Metab., 99: 561-569. Search in Google Scholar